《细胞周期基因是肝细胞癌潜在的诊断和预后生物标志物》勘误
Corrigendum to "Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma".
作者信息
Liping Xu, Jia Li, Qi Chen, Lian Yang, Dongen Li, Jianshuai Jiang
机构信息
Department of Hepatobiliary Pancreatic Surgery, Ningbo First Hospital, Ningbo, Zhejiang Province, China.
Department of Breast and Thyroid, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
出版信息
Biomed Res Int. 2020 Nov 21;2020:8679532. doi: 10.1155/2020/8679532. eCollection 2020.
Abstract
[This corrects the article DOI: 10.1155/2020/6206157.].
摘要
[本文更正了文章的数字对象标识符：10.1155/2020/6206157。]
相似文献
1
Corrigendum to "Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma".《细胞周期基因是肝细胞癌潜在的诊断和预后生物标志物》勘误
Biomed Res Int. 2020 Nov 21;2020:8679532. doi: 10.1155/2020/8679532. eCollection 2020.
2
Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.勘误：CDT1是一种用于肝细胞癌的新型预后和预测生物标志物。
Front Oncol. 2021 Nov 9;11:801970. doi: 10.3389/fonc.2021.801970. eCollection 2021.
3
Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.勘误：与原发性胆汁酸生物合成及肝细胞癌肿瘤微环境相关的线粒体相关预后生物标志物的鉴定。
Front Oncol. 2022 Jan 17;11:843623. doi: 10.3389/fonc.2021.843623. eCollection 2021.
4
Corrigendum: CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis.勘误：CCDC25可能是肝细胞癌的潜在诊断和预后标志物：来自微阵列分析的结果。
Front Surg. 2023 Mar 28;10:1175721. doi: 10.3389/fsurg.2023.1175721. eCollection 2023.
5
Corrigendum: Single-cell RNA sequencing reveals the role of phosphorylation-related genes in hepatocellular carcinoma stem cells.勘误：单细胞RNA测序揭示磷酸化相关基因在肝癌干细胞中的作用。
Front Cell Dev Biol. 2023 Oct 23;11:1045260. doi: 10.3389/fcell.2023.1045260. eCollection 2023.
6
Corrigendum to "The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma".《肾透明细胞癌中SLC家族作为候选诊断和预后生物标志物》勘误
Biomed Res Int. 2020 Dec 10;2020:1025178. doi: 10.1155/2020/1025178. eCollection 2020.
7
Corrigendum: Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.勘误：单细胞转录组分析揭示恶性肝细胞亚群的代谢变化及预后价值并预测肝细胞癌的新治疗药物。
Front Oncol. 2023 Mar 8;13:1162375. doi: 10.3389/fonc.2023.1162375. eCollection 2023.
8
Erratum: miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma [Corrigendum].勘误：miR-500a-3p是肝细胞癌的一种潜在预后生物标志物[勘误说明]。
Int J Gen Med. 2022 Feb 28;15:2215-2216. doi: 10.2147/IJGM.S364004. eCollection 2022.
9
Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer.勘误：对HAVCR1作为泛癌预后和诊断标志物的综合分析。
Front Genet. 2024 Jan 26;15:1357409. doi: 10.3389/fgene.2024.1357409. eCollection 2024.
10
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.勘误：肝细胞癌诊断和预后新型生物标志物的鉴定与验证。
Front Oncol. 2020 Nov 20;10:617539. doi: 10.3389/fonc.2020.617539. eCollection 2020.
本文引用的文献
1
Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.细胞周期基因是肝细胞癌潜在的诊断和预后生物标志物。
Biomed Res Int. 2020 Jun 7;2020:6206157. doi: 10.1155/2020/6206157. eCollection 2020.
Zotero 插件